More answers like this
Grok 4.5Oct 24, 2026x-ai/grok-4.5-20260708

Is the US prepared to deal with another pandemic or widespread health crisis?

No, the United States is not fully prepared for another pandemic or major widespread health crisis, though it has made meaningful improvements in some technical areas since COVID-19. Assessments from the Government Accountability Office (GAO), the Bipartisan Commission on Biodefense, Trust for America’s Health (TFAH), CDC testimony, independent experts, and administration reports consistently highlight progress alongside persistent structural gaps, incomplete implementation of lessons learned, funding instability, coordination challenges, and recent setbacks that leave the nation vulnerable.[1][2]

Post-COVID Improvements

The U.S. response to COVID-19 exposed major weaknesses (e.g., depleted stockpiles, slow testing scale-up, data silos, supply chain failures, and fragmented leadership), but it also drove investments and reforms:

•Strategic National Stockpile (SNS): Significantly restocked. By early 2025 reporting, it held roughly 70 times more N95 respirators, 34 times more gloves, 50 times more isolation gowns, and 10 times more ventilators than pre-pandemic levels. It has supported responses to H5N1 (PPE and antivirals), mpox (vaccines and therapeutics), and other incidents. Sustainment includes quality assurance, shelf-life management, and efforts to preposition assets closer to states/localities.[3][4]
•Surveillance and data systems: Dramatic expansion of electronic case reporting (from under 200 healthcare facilities pre-COVID to over 45,000–48,000 by late 2024) and syndromic surveillance (over 80% of hospital EDs). Wastewater surveillance, traveler genomic surveillance, and near-real-time hospital data improved early warning for threats like H5N1 and variants. CDC created “warm base” lab partnerships for surge testing.[5][3]
•Medical countermeasures and platforms: BARDA and related efforts advanced vaccines, therapeutics, and diagnostics (including mRNA platforms adaptable to new threats). Investments supported mpox/smallpox tools and H5N1 vaccine stockpiling/candidates. Project BioShield and PHEMCE frameworks advanced readiness, though funding shortfalls persist.[6]
•Coordination structures: Congress established the White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2022–2023 as a permanent coordinating body. CDC reorganized around lessons learned; global health security investments exceeded $3 billion since 2020, aiding partner countries and outbreak responses (Ebola, mpox, etc.).[7][3]
•Other: Expanded nurse licensure compact (for surge staffing), some accreditation gains in public health/emergency management, and playbooks/roadmaps left by the prior administration.[8]

These changes mean the U.S. starts from a stronger technical baseline than in early 2020 for certain threats.

Persistent and Emerging Gaps

Independent reviews emphasize that progress is incomplete and uneven:

•GAO findings: As of mid-2024, of ~428 recommendations related to COVID lessons, about 220 remained open. HHS leadership/coordination of public health emergencies has been on GAO’s High-Risk List since 2022 due to deficiencies in situational awareness/biosurveillance networks (mandated years earlier but unfinished), testing strategies, medical countermeasure manufacturing, supply mitigation, and interagency roles. Lessons span planning, partner collaboration, clear communication, data sharing, program integrity, and flexibilities.[1][1]
•Bipartisan Commission on Biodefense (2024 National Blueprint): The nation “remains dangerously vulnerable.” It issued 36 recommendations and 185 action items across leadership, intelligence/deterrence, science/tech, preparedness, detection/surveillance, and response/recovery. Key calls include stronger White House leadership (e.g., codifying National Security Advisor role and a deputy for day-to-day biodefense), a quadrennial biodefense review, replacing the ineffective BioWatch airborne detection system, reducing indoor pathogen transmission via R&D, and sustained “on all the time” (not boom-bust) investment. Fragmentation across 15+ departments/agencies and 150+ congressional committees hampers efforts. Had earlier recommendations been fully implemented, COVID impacts would have been less severe.[2][9]
•State and local readiness (TFAH Ready or Not 2025): 21 states + DC in high-performance tier; 16 medium; 13 low. Strengths include nurse compact adoption and accreditation. Weaknesses: public health funding cuts in 14 states (FY2024), low flu vaccination (~47% in 2023–24 vs. 70% goal), limited paid sick leave access, high avoidable mortality in some regions/disparities, and lab/workforce surge capacity issues. All states need stronger investment.[8]
•Funding and sustainment: PHEMCE projected multi-billion shortfalls if appropriations stay flat. PAHPA (core authorization) has faced reauthorization/funding gaps. Core public health infrastructure and workforce remain under-resourced long-term; COVID supplemental funds have largely expired. Antimicrobial resistance, supply chain vulnerabilities (especially domestic manufacturing), and healthcare access inequities persist.[6]
•Leadership, trust, and politics: Ambiguities in federal-state roles and authorities continue. Public trust erosion, polarization, and misinformation complicate response. Workforce shortages (public health, clinical) and chronic disease burdens increase vulnerability.

Recent Developments and Ongoing Risks (2025–2026 Context)

Policy shifts under the subsequent administration have raised alarms among many experts about backsliding:

•OPPR was largely emptied (staff departures, leadership gaps) before partial restaffing with minimal personnel—far short of prior capacity—drawing criticism that it exists “in name only” or is inadequate for coordination.[10][11]
•Reports of cuts or freezes to NIH/CDC biodefense/pandemic R&D (including mRNA-related work), databases, surveillance elements, and staffing have been described by former officials and scientists as damaging core capabilities and leaving “huge gaps.” Some biosecurity rebuilding has been noted amid AI-related biothreat concerns, but overall expert consensus leans toward weakened readiness.[12][12]
•H5N1 (bird flu) in dairy cattle and poultry (with limited human cases, mostly mild/occupational but including severe ones) has tested systems. Responses include testing, PPE/antivirals from SNS, vaccine candidates/stockpiling, and wastewater monitoring, but critics note incomplete containment, worker protections, and preparedness for potential human-to-human adaptation. Other outbreaks (measles resurgence, hantavirus, etc.) highlight ongoing stresses.[13][14]

Experts (e.g., former OPPR leaders, virologists, public health groups) frequently state the U.S. is “not ready,” lags on lessons implementation, and faces higher risks from natural, accidental, or deliberate biological threats. Probability estimates of another major pandemic remain elevated (e.g., significant chance within decades). Global efforts (Pandemic Fund, IHR, etc.) help but depend on strong national capacities.[15][16]

Bottom Line and Path Forward

The U.S. has better tools, stockpiles, and experience than pre-2020 and can handle many localized or moderate threats more effectively. However, it lacks the sustained leadership, fully implemented coordination frameworks, resilient funding, robust workforce/infrastructure at all levels, modern detection, and societal cohesion needed for a high-impact, nationwide (or worse) crisis comparable to or exceeding COVID-19. Boom-bust cycles, incomplete reforms, and recent disruptions compound risks from evolving threats (zoonoses, AMR, biotech/AI-enabled risks, climate-amplified events).

Full preparedness would require sustained bipartisan investment, implementing open GAO/Bipartisan Commission recommendations, stabilizing OPPR and core agencies, strengthening state/local capacity and equity, modernizing detection/manufacturing, rebuilding trust through transparent communication, and treating biodefense as continuous national security priority rather than crisis-driven. Without these, another major event would likely again reveal costly gaps in lives, economy, and confidence. Official roadmaps and playbooks exist as starting points, but execution and political will remain the decisive factors.

Citations (16)

  1. 1gao.govGovernment
    https://www.gao.gov/products/gao-24-107175

    Backs: “Assessments from the Government Accountability Office (GAO), the Bipartisan Commission on Biodefense, Trust for America’s Health (TFAH), CDC testimony, independent experts, and administration reports consistently highlight progress alongside persistent structural gaps, incomplete implementation of lessons learned,…”

  2. 2biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/

    Backs: “Assessments from the Government Accountability Office (GAO), the Bipartisan Commission on Biodefense, Trust for America’s Health (TFAH), CDC testimony, independent experts, and administration reports consistently highlight progress alongside persistent structural gaps, incomplete implementation of lessons learned,…”

  3. 3archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/

    Backs: “Sustainment includes quality assurance, shelf-life management, and efforts to preposition assets closer to states/localities.”

  4. 4aspr.govGovernment
    https://www.aspr.gov/news-updates/blog/2025-12/stand-ready-move-fast-save-lives

    Backs: “Sustainment includes quality assurance, shelf-life management, and efforts to preposition assets closer to states/localities.”

  5. 5cdc.govGovernment
    https://www.cdc.gov/washington/testimony/2024/t20241114.htm

    Backs: “Wastewater surveillance, traveler genomic surveillance, and near-real-time hospital data improved early warning for threats like H5N1 and variants. CDC created “warm base” lab partnerships for surge testing.”

  6. 6center-forward.orgNonprofits and think tanks
    https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/

    Backs: “Project BioShield and PHEMCE frameworks advanced readiness, though funding shortfalls persist.”

  7. 7ucsb.eduAcademic
    https://www.presidency.ucsb.edu/documents/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report

    Backs: “CDC reorganized around lessons learned; global health security investments exceeded $3 billion since 2020, aiding partner countries and outbreak responses (Ebola, mpox, etc.).”

  8. 8tfah.orgNonprofits and think tanks
    https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/

    Backs: “Expanded nurse licensure compact (for surge staffing), some accreditation gains in public health/emergency management, and playbooks/roadmaps left by the prior administration.”

  9. 9axios.comNews and mediaquality 0.90
    https://www.axios.com/2024/05/07/biodefense-buildup-urged-exclusive-report

    Backs: “Had earlier recommendations been fully implemented, COVID impacts would have been less severe.”

  10. 10notus.orgNot yet classified
    https://www.notus.org/health-science/white-house-pandemic-preparedness

    Backs: “OPPR was largely emptied (staff departures, leadership gaps) before partial restaffing with minimal personnel—far short of prior capacity—drawing criticism that it exists “in name only” or is inadequate for coordination.”

  11. 11cnn.comNews and mediaquality 0.66
    https://www.cnn.com/2025/03/17/health/pandemic-preparedness-office-trump-bird-flu

    Backs: “OPPR was largely emptied (staff departures, leadership gaps) before partial restaffing with minimal personnel—far short of prior capacity—drawing criticism that it exists “in name only” or is inadequate for coordination.”

  12. 12science.orgAcademic
    https://www.science.org/content/article/trump-administration-dismantling-efforts-fight-next-pandemic

    Backs: “Reports of cuts or freezes to NIH/CDC biodefense/pandemic R&D (including mRNA-related work), databases, surveillance elements, and staffing have been described by former officials and scientists as damaging core capabilities and leaving “huge gaps.” Some biosecurity rebuilding has been noted amid AI-related biothreat…”

  13. 13nejm.orgAcademic
    https://www.nejm.org/doi/full/10.1056/NEJMp2406427

    Backs: “Other outbreaks (measles resurgence, hantavirus, etc.) highlight ongoing stresses.”

  14. 14apnews.comNews and mediaquality 1.00
    https://apnews.com/article/pandemic-preparedness-trump-biden-192518a8e1414cf40bafefdc2bf1f5ca

    Backs: “Other outbreaks (measles resurgence, hantavirus, etc.) highlight ongoing stresses.”

  15. 15stimson.orgNonprofits and think tanks
    https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/

    Backs: “Global efforts (Pandemic Fund, IHR, etc.) help but depend on strong national capacities.”

  16. 16theguardian.comNews and mediaquality 0.75
    https://www.theguardian.com/us-news/2026/may/17/pandemic-preparedness-after-covid

    Backs: “Global efforts (Pandemic Fund, IHR, etc.) help but depend on strong national capacities.”